A case of a 16-year-old girl with malignant histiocytosis involving the lymph nodes, bone marrow, peripheral blood, liver, and spleen is described. This patient achieved a complete remission with cyclic quadruple chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, and prednisone
Combination Chemotherapy in Histiocytosis X
β Scribed by Komp, Diane M. ;Vietti, Teresa J. ;Berry, D. H. ;Starling, Kenneth A. ;Haggard, Mary Ellen ;George, Stephen L.
- Publisher
- John Wiley and Sons
- Year
- 1977
- Tongue
- English
- Weight
- 333 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Twentyβfive children with generalized histiocytosis X were treated with a combination of cyclophosphamide, vinblastine, and prednisone: 8 patients experienced complete response, 8 partial response, 2 improvement, and 7 no response. Response rates for children over 1 year of age were higher than those reported for single agents.
Twelve children are now off therapy with no evidence of disease for 10β50 months.
Very poor response rates and high toxicity were seen in children less than 1 year of age. The two infants who eventually achieved CR did so by other therapies.
Further trials in combination chemotherapy must weigh possible longβterm effects of such therapy against the prospect of more rapid disease control.
π SIMILAR VOLUMES
Twenty-eight patients with histiocytosis X (HX) who had bone marrow aspirates andlor trephine biopsies taken at diagnosis were studied. Five of the 28 patients (18%) had bone marrow specimens with clusters of benign histiocytes characteristic of histiocytosis X. Several statistically significant cli
Langerhans' cell histiocytosis (LCH) (previously histiocytosis X) is an infrequent disease with protean clinical manifestations and an unpredictable course. The role of radiotherapy in the soft tissue complications of LCH was evaluated in this retrospective study of 40 patients seen in two major Phi